Budget impact of tepotinib in the treatment of adult patients with metastatic non-small cell lung cancer harboring METex14 skipping alterations in the United States

Matthew Stargardtera Evidera, Evidence Synthesis, Modeling, & Communication, Bethesda, MD, USA

Ali McBrideb The University of Arizona College of Pharmacy – Tucson, Tucson, AZ, USA

Jon Toshc Evidera, Evidence Synthesis, Modeling, & Communication, London, UK

Rameet Sachdeva Evidera, Evidence Synthesis, Modeling, & Communication, Bethesda, MD, USA

Mo Yangd EMD Serono, Rockland, MA, USA

Apoorva Ambavanea Evidera, Evidence Synthesis, Modeling, & Communication, Bethesda, MD, USA

Madhav Mittala Evidera, Evidence Synthesis, Modeling, & Communication, Bethesda, MD, USA

Helene Vioixe Merck KGaA, Darmstadt, Germany

Frank Xiaoqing Liud EMD Serono, Rockland, MA, USACorrespondence[email protected]

Your download is now in progress and you may close this window